YHLO Helps China’s Top Ranking Hospital PUMCH to Upgrade from Traditional ELISA to CLIA Technology
By LabMedica International staff writers Posted on 06 Jan 2021 |

Image: iModules Integration System for Immunoassay (Photo courtesy of Shenzhen YHLO Biotech Co., Ltd.)
Shenzhen YHLO Biotech Co., Ltd. (Shenzhen, China) has helped China’s top ranking hospital, Peking Union Medical College Hospital (PUMCH; Beijing, China), to successfully upgrade its laboratory from the traditional ELISA (enzyme-linked immunoassay) technology to CLIA (chemiluminescence immunoassay) technology.
PUMCH, founded by the Rockefeller Foundation in 1921, has been designated by China’s Ministry of Health as one of the most authoritative centers for diagnosis and treatment of complex diseases. PUMCH’s department of Rheumatology and Immunology is the earliest dedicated department for rheumatology and immunology in China. The department’s laboratory is capable of diagnosing nearly 100 kinds of auto-antibodies, making it one of the largest auto-antibody diagnosing centers in China. In August 2020, the department upgraded its laboratory from the traditional ELISA technology to CLIA technology with the cooperation of YHLO.
With the help of YHLO’s iModules Integration System for Immunoassay, PUMCH has become the first among the top Chinese hospitals to establish a fully automated assembly line. YHLO’s iModules series features a modular design that offers flexibility for expansion. With its high throughput, fast speed and multiple parameters, the series helps to process a higher number of samples in the laboratory, improve diagnostic results and shorten turnaround time. The parameters on the iModules platform include dsDNA IgG, SSA IgG, SSB IgG, RNP70 IgG, Sm IgG, Jo-1 IgG, Scl-70 IgG, anti-CCP, MPO IgG, PR3 IgG, Cardiolipin IgG/IgA/IgM/total and β2 Glycoprotein IgG/IgA/IgM/total, etc., providing more accurate and reliable quantitative results.
Related Links:
Shenzhen YHLO Biotech Co., Ltd.
Peking Union Medical College Hospital
PUMCH, founded by the Rockefeller Foundation in 1921, has been designated by China’s Ministry of Health as one of the most authoritative centers for diagnosis and treatment of complex diseases. PUMCH’s department of Rheumatology and Immunology is the earliest dedicated department for rheumatology and immunology in China. The department’s laboratory is capable of diagnosing nearly 100 kinds of auto-antibodies, making it one of the largest auto-antibody diagnosing centers in China. In August 2020, the department upgraded its laboratory from the traditional ELISA technology to CLIA technology with the cooperation of YHLO.
With the help of YHLO’s iModules Integration System for Immunoassay, PUMCH has become the first among the top Chinese hospitals to establish a fully automated assembly line. YHLO’s iModules series features a modular design that offers flexibility for expansion. With its high throughput, fast speed and multiple parameters, the series helps to process a higher number of samples in the laboratory, improve diagnostic results and shorten turnaround time. The parameters on the iModules platform include dsDNA IgG, SSA IgG, SSB IgG, RNP70 IgG, Sm IgG, Jo-1 IgG, Scl-70 IgG, anti-CCP, MPO IgG, PR3 IgG, Cardiolipin IgG/IgA/IgM/total and β2 Glycoprotein IgG/IgA/IgM/total, etc., providing more accurate and reliable quantitative results.
Related Links:
Shenzhen YHLO Biotech Co., Ltd.
Peking Union Medical College Hospital
Latest Industry News
- AMP Releases Best Practice Recommendations to Guide Clinical Laboratories Offering HRD Testing
- Illumina Acquires SomaLogic to Accelerate Proteomics Business
- Qiagen and Gencurix Partner on Development of QIAcuity Digital PCR IVD Assay
- QIAGEN and Incyte Enter into Precision Medicine Collaboration
- bioMérieux Acquires Day Zero Diagnostics Solutions and Technologies
- Aston University and BG Research Partner to Commercialize Groundbreaking Medical Diagnostic
- Fujirebio Collaborates with Stanford Medicine to Advance Infectious Disease Research
- QuidelOrtho to Acquire MDx Company LEX Diagnostics
- QIAGEN Enters into New Strategic Partnerships for Expanding MRD Testing Portfolio in Oncology
- Danaher and AstraZeneca Partner on Next Generation AI-Powered Diagnostics
- EuroMedLab 2025 Showcases Latest Technologies and Innovations in Laboratory Medicine
- Qiagen Acquires NGS Analysis Software Company Genoox
- Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
- Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
- New Collaboration to Advance Microbial Identification for Infectious Disease Diagnostics
- Tecan Acquires ELISA Immunoassay Assets from Revvity's Cisbio Bioassays
Channels
Clinical Chemistry
view channel
New Reference Measurement Procedure Standardizes Nucleic Acid Amplification Test Results
Nucleic acid amplification tests (NAATs) play a key role in diagnosing a wide range of infectious diseases. These tests are generally known for their high sensitivity and specificity, and they can be developed... Read more
Pen-Like Tool Quickly and Non-Invasively Detects Opioids from Skin
Opioid drugs such as fentanyl, morphine, and oxycodone are the primary substances associated with overdose cases in the United States. Standard drug screening procedures typically involve collecting blood,... Read moreMolecular Diagnostics
view channel
New Blood Test for Leukemia Risk Detection Could Replace Bone Marrow Sampling
Myelodysplastic syndrome (MDS) is a condition typically associated with aging, where blood stem cells fail to develop into fully functional blood cells. Early and accurate diagnosis is vital, as MDS can... Read more
Blood Test Detects Preeclampsia Risk Months Before Symptoms Appear
Preeclampsia, a pregnancy-related complication characterized by elevated blood pressure and organ dysfunction, remains a major contributor to maternal and infant health issues globally. Existing screening... Read moreHematology
view channel
Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results
Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more
First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes
Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read moreImmunology
view channel
Blood Test Detects Organ Rejection in Heart Transplant Patients
Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Liquid Biopsy Approach to Transform Diagnosis, Monitoring and Treatment of Lung Cancer
Lung cancer continues to be a major contributor to cancer-related deaths globally, with its biological complexity and diverse regulatory processes making diagnosis and treatment particularly difficult.... Read more
Computational Tool Exposes Hidden Cancer DNA Changes Influencing Treatment Resistance
Structural changes in tumor DNA are among the most damaging genetic alterations in cancer, yet they often go undetected, particularly when tissue samples are degraded or of low quality. These hidden genomic... Read moreMicrobiology
view channel
Credit Card-Sized Test Boosts TB Detection in HIV Hotspots
Current tuberculosis (TB) tests face major limitations when it comes to accurately diagnosing the infection in individuals living with HIV. HIV, a frequent co-infection with TB, complicates detection by... Read more
Fecal Metabolite Profiling Predicts Mortality in Critically Ill Patients
Critically ill patients in medical intensive care units (MICUs) often suffer from conditions such as acute respiratory distress syndrome (ARDS) or sepsis, which are linked to reduced diversity of gut microbiota... Read more
Portable Molecular POC System Rules Out UTIs in Just 35 Minutes
Urinary tract infections (UTIs) represent a massive burden on patients and healthcare systems. There are over 400 million UTI cases globally each year, of which around 90% are in women. Fast and accurate... Read more
POC Lateral Flow Test Detects Deadly Fungal Infection Faster Than Existing Techniques
Diagnosing mucormycosis—an aggressive and often deadly fungal infection—remains a major challenge due to the disease’s rapid progression and the lack of fast, accurate diagnostic tools. The problem became... Read morePathology
view channel
Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response
Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Clinical AI Solution for Automatic Breast Cancer Grading Improves Diagnostic Accuracy
Labs that use traditional image analysis methods often suffer from bottlenecks and delays. By digitizing their pathology practices, labs can streamline their work, allowing them to take on larger caseloads... Read more
Saliva-Based Testing to Enable Early Detection of Cancer, Heart Disease or Parkinson’s
Saliva is one of the most accessible biological fluids, yet it remains underutilized in clinical practice. While saliva samples are used to perform genetic tests to determine, for example, paternity, the... Read moreTechnology
view channel
New POC Biosensing Technology Improves Detection of Molecular Biomarkers
Traditional diagnostic procedures in medicine typically involve sending a patient’s blood or tissue samples to clinical laboratories, where trained scientists perform testing and data interpretation.... Read more